T.M. Kim

579 total citations
14 papers, 416 citations indexed

About

T.M. Kim is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, T.M. Kim has authored 14 papers receiving a total of 416 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 8 papers in Pulmonary and Respiratory Medicine and 6 papers in Molecular Biology. Recurrent topics in T.M. Kim's work include Lung Cancer Treatments and Mutations (7 papers), Pancreatic and Hepatic Oncology Research (3 papers) and Colorectal Cancer Treatments and Studies (2 papers). T.M. Kim is often cited by papers focused on Lung Cancer Treatments and Mutations (7 papers), Pancreatic and Hepatic Oncology Research (3 papers) and Colorectal Cancer Treatments and Studies (2 papers). T.M. Kim collaborates with scholars based in South Korea, United States and Spain. T.M. Kim's co-authors include Dae Seog Heo, Yoon Kyung Jeon, Bhumsuk Keam, Soo‐Chan Kim, S.-H. Lee, Yoon‐La Choi, Valsamo Anagnostou, Hyun Ae Jung, Jin Seok Ahn and Myung‐Ju Ahn and has published in prestigious journals such as Annals of Oncology, European Journal of Cancer and Journal of Thoracic Oncology.

In The Last Decade

T.M. Kim

14 papers receiving 412 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
T.M. Kim South Korea 7 266 152 134 127 86 14 416
Laura Palmeri Italy 12 285 1.1× 130 0.9× 101 0.8× 85 0.7× 85 1.0× 20 390
Audrey Gros France 11 233 0.9× 188 1.2× 142 1.1× 80 0.6× 73 0.8× 26 449
M.C. Cox United States 10 180 0.7× 177 1.2× 117 0.9× 91 0.7× 74 0.9× 23 429
Yanfen Feng China 14 201 0.8× 88 0.6× 109 0.8× 130 1.0× 85 1.0× 39 429
H. S. Hochster United States 12 430 1.6× 130 0.9× 112 0.8× 79 0.6× 45 0.5× 21 517
Marie Cornic France 13 256 1.0× 95 0.6× 301 2.2× 133 1.0× 210 2.4× 24 548
Mark Knapp United States 11 226 0.8× 70 0.5× 255 1.9× 92 0.7× 46 0.5× 20 395
Igor Gorbatchevsky United States 9 242 0.9× 93 0.6× 291 2.2× 159 1.3× 36 0.4× 36 512
Mercedes M. Condy United States 8 252 0.9× 328 2.2× 78 0.6× 105 0.8× 56 0.7× 15 456
Fernando Hurtado de Mendoza Peru 8 298 1.1× 84 0.6× 161 1.2× 64 0.5× 69 0.8× 16 401

Countries citing papers authored by T.M. Kim

Since Specialization
Citations

This map shows the geographic impact of T.M. Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T.M. Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T.M. Kim more than expected).

Fields of papers citing papers by T.M. Kim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T.M. Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T.M. Kim. The network helps show where T.M. Kim may publish in the future.

Co-authorship network of co-authors of T.M. Kim

This figure shows the co-authorship network connecting the top 25 collaborators of T.M. Kim. A scholar is included among the top collaborators of T.M. Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T.M. Kim. T.M. Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
2.
Kim, T.M., et al.. (2022). Mechanisms of resistance to mobocertinib in EGFR exon 20 insertion-mutant non-small cell lung cancer (NSCLC). European Journal of Cancer. 174. S110–S111. 1 indexed citations
3.
4.
Shim, Joonho, Hongui Cha, Soo‐Chan Kim, et al.. (2020). HLA-corrected tumor mutation burden and homologous recombination deficiency for the prediction of response to PD-(L)1 blockade in advanced non-small-cell lung cancer patients. Annals of Oncology. 31(7). 902–911. 93 indexed citations
5.
Jang, Ji-Young, Jaemoon Koh, Dohee Kwon, et al.. (2019). P2.04-42 PD-L1-Mediated Enhancement of Hexokinase 2 Expression Is Inversely Related to T-Cell Effector Gene Expression in Non-Small-Cell Lung Cancer. Journal of Thoracic Oncology. 14(10). S724–S725. 1 indexed citations
6.
Kim, S.-B., Bhumsuk Keam, Seong Hoon Shin, et al.. (2019). First in human, a phase I study of ISU104, a novel ErbB3 monoclonal antibody, in patients with advanced solid tumours. Annals of Oncology. 30. v168–v168. 4 indexed citations
7.
Kim, T.M., Chan‐Young Ock, Bhumsuk Keam, et al.. (2019). Phase II study of osimertinib in NSCLC patients with EGFR exon 20 insertion mutation: A multicenter trial of the Korean Cancer Study Group (LU17-19). Annals of Oncology. 30. v628–v628. 29 indexed citations
8.
Kim, Yoon Jun, Chan‐Young Ock, Bhumsuk Keam, et al.. (2018). OA11.05 Phase II Study of Sunitinib in Patients with Thymic Carcinoma Previously Treated with Platinum-Based Chemotherapy (KOSMIC Trial). Journal of Thoracic Oncology. 13(10). S346–S347. 8 indexed citations
9.
Yoo, Shin Hye, et al.. (2017). Generalization and representativeness of phase III immune checkpoint inhibitor trials in NSCLC. Annals of Oncology. 28. v472–v473. 1 indexed citations
10.
Knox, Jennifer J., Carlos H. Barrios, T.M. Kim, et al.. (2017). Final overall survival analysis for the phase II RECORD-3 study of first-line everolimus followed by sunitinib versus first-line sunitinib followed by everolimus in metastatic RCC. Annals of Oncology. 28(6). 1339–1345. 84 indexed citations
11.
12.
Lee, Jake June-Koo, Sandra Louzada, Yu An, et al.. (2016). Complex chromosomal rearrangements by single catastrophic pathogenesis in NUT midline carcinoma. Annals of Oncology. 28(4). 890–897. 52 indexed citations
13.
Kang, Seok Jin, Jin Won Choi, T.M. Kim, et al.. (2009). Development of a pheasant interspecies primordial germ cell transfer to chicken embryo: Effect of donor cell sex on chimeric semen production. Theriogenology. 72(4). 519–527. 14 indexed citations
14.
Kim, T.M., Yoon Kyung Jeon, Young Seon Hong, et al.. (2008). Clinical heterogeneity of extranodal NK/T-cell lymphoma, nasal type: a national survey of the Korean Cancer Study Group. Annals of Oncology. 19(8). 1477–1484. 125 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Laura Palmeri Breakdown of academic impact, for papers by Audrey Gros Breakdown of academic impact, for papers by M.C. Cox Breakdown of academic impact, for papers by Yanfen Feng Breakdown of academic impact, for papers by H. S. Hochster Breakdown of academic impact, for papers by Marie Cornic Breakdown of academic impact, for papers by Mark Knapp Breakdown of academic impact, for papers by Igor Gorbatchevsky Breakdown of academic impact, for papers by Mercedes M. Condy Breakdown of academic impact, for papers by Fernando Hurtado de Mendoza
Rankless by CCL
2026